Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Elevated ß-catenin pathway as a novel target for patients with resistance to EGF receptor targeting drugs.

Elevated ß-catenin pathway as a novel target for patients with resistance to EGF receptor targeting drugs. Sci Rep. 2015 Aug 13; 5:13076.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.